24 marzo 2015
A new approach to treating B cell acute lymphoblastic leukaemia has been uncovered by researchers. B cell acute lymphoblastic leukaemia, or B-ALL, is the most common tumor disease in children and also occurs in adults. It develops when signalling pathways in immature B cells, or pre-B cells, are dysregulated. These studies could change the way we think about clinical therapies for treating these tumor diseases, authors say.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/Fvoz7-CTXXE/150324084518.htm
